Sigma Healthcare Ltd
S5YA
Company Profile
Business description
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.
Contact
Sector
Healthcare
Stock type
Industry
Medical Distribution
Fiscal Year End
Employees
Stocks News & Analysis
stocks
Signs of a turnaround for undervalued ASX share
Market likes the payoff from early efforts at reining in costs.
stocks
Australia has the highest dividend yields in the world, so why the endless chase for even higher yields?
Ashley Owen explores why investors' insatiable thirst for higher yields leads to unnecessarily complicating their portfolio.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,825.10 | 20.90 | 0.24% |
CAC 40 | 8,178.54 | 14.43 | 0.18% |
DAX 40 | 22,513.42 | 98.60 | -0.44% |
Dow JONES (US) | 44,546.08 | 165.35 | -0.37% |
FTSE 100 | 8,732.46 | 32.26 | -0.37% |
HKSE | 22,620.33 | 805.96 | 3.69% |
NASDAQ | 20,026.77 | 81.13 | 0.41% |
Nikkei 225 | 39,149.43 | 312.04 | -0.79% |
NZX 50 Index | 12,989.18 | 83.20 | 0.64% |
S&P 500 | 6,114.63 | 0.44 | -0.01% |
S&P/ASX 200 | 8,555.80 | 15.80 | 0.19% |
SSE Composite Index | 3,346.72 | 14.24 | 0.43% |